SCHEMBL742340

SCHEMBL742340

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCOCC4)cc3)n[nH]c2s1)c1cccc(F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.55
BCR P11274 2/20 0.55
RAB9A P51151 7/20 0.47
NPC1 O15118 5/20 0.47
TP53 P04637 3/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
AURKA O14965 4/20 0.45
HIF1A Q16665 4/20 0.43
EPAS1 Q99814 4/20 0.43
LMNA P02545 2/20 0.42
KCNH2 Q12809 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40
POLB P06746 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740581 0.93 ABL1 (0.63) ABL1BCRRAB9ANPC1TP53
SCHEMBL741731 0.93 ABL1 (0.61) ABL1BCRRAB9ANPC1TP53
SCHEMBL742939 0.93 ABL1 (0.64) ABL1BCRRAB9ANPC1TP53
SCHEMBL739685 0.93 ABL1 (0.56) ABL1BCRRAB9ANPC1TP53
SCHEMBL742258 0.92 ABL1 (0.65) ABL1BCRRAB9ANPC1ALDH1A1
SCHEMBL739902 0.90 LMNA (0.54) ABL1BCRRAB9ANPC1TP53
SCHEMBL741174 0.90 AURKA (0.54) ABL1BCRAURKALMNAKDR
SCHEMBL2439030 0.89 RAB9A (0.46) ABL1BCRRAB9ANPC1TP53
SCHEMBL740144 0.88 ABL1 (0.52) ABL1BCRRAB9ANPC1TP53
SCHEMBL1779566 0.87 ABL1 (0.59) ABL1BCRRAB9ASMN1; SMN2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP disclosed